MARKER THERAPEUTICS (MRKR) Competitors $1.56 +0.06 (+4.00%) Closing price 04:00 PM EasternExtended Trading$1.51 -0.05 (-3.46%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MRKR vs. VNRX, INCR, PMVP, VTGN, GNTA, RPTX, IRD, ANEB, IKNA, and KLTOShould you be buying MARKER THERAPEUTICS stock or one of its competitors? The main competitors of MARKER THERAPEUTICS include VolitionRx (VNRX), InterCure (INCR), PMV Pharmaceuticals (PMVP), VistaGen Therapeutics (VTGN), Genenta Science (GNTA), Repare Therapeutics (RPTX), Opus Genetics (IRD), Anebulo Pharmaceuticals (ANEB), Ikena Oncology (IKNA), and Klotho Neurosciences (KLTO). These companies are all part of the "pharmaceutical products" industry. MARKER THERAPEUTICS vs. Its Competitors VolitionRx InterCure PMV Pharmaceuticals VistaGen Therapeutics Genenta Science Repare Therapeutics Opus Genetics Anebulo Pharmaceuticals Ikena Oncology Klotho Neurosciences MARKER THERAPEUTICS (NASDAQ:MRKR) and VolitionRx (NYSE:VNRX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability. Is MRKR or VNRX more profitable? MARKER THERAPEUTICS has a net margin of -224.46% compared to VolitionRx's net margin of -2,321.14%. VolitionRx's return on equity of 0.00% beat MARKER THERAPEUTICS's return on equity.Company Net Margins Return on Equity Return on Assets MARKER THERAPEUTICS-224.46% -101.87% -83.02% VolitionRx -2,321.14%N/A -163.39% Do insiders and institutionals have more ownership in MRKR or VNRX? 22.4% of MARKER THERAPEUTICS shares are held by institutional investors. Comparatively, 8.1% of VolitionRx shares are held by institutional investors. 14.5% of MARKER THERAPEUTICS shares are held by company insiders. Comparatively, 10.4% of VolitionRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, MRKR or VNRX? MARKER THERAPEUTICS has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500. Comparatively, VolitionRx has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Which has stronger earnings & valuation, MRKR or VNRX? MARKER THERAPEUTICS has higher revenue and earnings than VolitionRx. VolitionRx is trading at a lower price-to-earnings ratio than MARKER THERAPEUTICS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMARKER THERAPEUTICS$6.59M2.68-$10.73M-$1.33-1.17VolitionRx$1.31M59.61-$35.32M-$0.27-2.78 Do analysts rate MRKR or VNRX? MARKER THERAPEUTICS presently has a consensus target price of $13.17, suggesting a potential upside of 744.02%. VolitionRx has a consensus target price of $3.50, suggesting a potential upside of 366.67%. Given MARKER THERAPEUTICS's stronger consensus rating and higher possible upside, equities research analysts clearly believe MARKER THERAPEUTICS is more favorable than VolitionRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MARKER THERAPEUTICS 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50VolitionRx 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media favor MRKR or VNRX? In the previous week, MARKER THERAPEUTICS had 1 more articles in the media than VolitionRx. MarketBeat recorded 2 mentions for MARKER THERAPEUTICS and 1 mentions for VolitionRx. MARKER THERAPEUTICS's average media sentiment score of 0.63 beat VolitionRx's score of 0.00 indicating that MARKER THERAPEUTICS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MARKER THERAPEUTICS 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive VolitionRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMARKER THERAPEUTICS beats VolitionRx on 13 of the 16 factors compared between the two stocks. Get MARKER THERAPEUTICS News Delivered to You Automatically Sign up to receive the latest news and ratings for MRKR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRKR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRKR vs. The Competition Export to ExcelMetricMARKER THERAPEUTICSMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.97M$2.50B$5.70B$9.51BDividend YieldN/A1.75%4.69%4.01%P/E Ratio-1.179.0528.0720.05Price / Sales2.68757.64448.5799.42Price / CashN/A165.2136.2258.56Price / Book0.905.168.665.87Net Income-$10.73M$30.99M$3.25B$258.55M7 Day Performance-8.24%7.74%4.20%2.23%1 Month Performance4.70%16.18%10.82%12.76%1 Year Performance-70.17%-1.03%34.70%19.36% MARKER THERAPEUTICS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRKRMARKER THERAPEUTICS4.5476 of 5 stars$1.56+4.0%$13.17+744.0%-72.2%$16.97M$6.59M-1.1760VNRXVolitionRx1.5738 of 5 stars$0.68+2.5%$3.50+411.2%-1.9%$71.20M$1.31M-1.9080INCRInterCure0.661 of 5 stars$1.55flatN/A-34.5%$70.63M$238.85M0.00350Positive NewsPMVPPMV Pharmaceuticals3.167 of 5 stars$1.35+7.1%$5.50+307.4%-11.7%$70.13MN/A-1.1450News CoveragePositive NewsHigh Trading VolumeVTGNVistaGen Therapeutics0.4606 of 5 stars$2.38flatN/A-26.4%$69.40M$490K-1.4340News CoverageGNTAGenenta Science2.7337 of 5 stars$3.78-4.5%$25.00+561.4%-12.1%$69.14MN/A0.007Positive NewsGap DownRPTXRepare Therapeutics2.6547 of 5 stars$1.57+4.7%$4.50+186.6%-60.1%$67.34M$53.48M-0.52180IRDOpus Genetics1.6496 of 5 stars$1.11-1.8%$7.33+560.7%N/A$66.22M$10.99M-0.5314ANEBAnebulo Pharmaceuticals2.0905 of 5 stars$1.61-3.0%$5.50+241.6%+35.0%$66.15MN/A-6.194News CoverageAnalyst ForecastIKNAIkena Oncology2.9881 of 5 stars$1.37-0.7%$3.00+119.0%-18.0%$66.11MN/A-1.5970News CoveragePositive NewsEarnings ReportAnalyst ForecastStock SplitHigh Trading VolumeKLTOKlotho NeurosciencesN/A$1.25-3.8%N/AN/A$65.88MN/A-3.47N/A Related Companies and Tools Related Companies VolitionRx Alternatives InterCure Alternatives PMV Pharmaceuticals Alternatives VistaGen Therapeutics Alternatives Genenta Science Alternatives Repare Therapeutics Alternatives Opus Genetics Alternatives Anebulo Pharmaceuticals Alternatives Ikena Oncology Alternatives Klotho Neurosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRKR) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MARKER THERAPEUTICS, INC. Please log in to your account or sign up in order to add this asset to your watchlist. Share MARKER THERAPEUTICS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRKR Stock Alerts